|Gebot||210,10 x 1100|
|Briefkurs||211,05 x 800|
|Tagesspanne||209,13 - 214,45|
|52-Wochen-Spanne||173,45 - 371,16|
|Beta (5 J., monatlich)||1,13|
|Kurs-Gewinn-Verhältnis (roll. Hochrechn.)||47,32|
|EPS (roll. Hochrechn.)||4,44|
|Gewinndatum||07. Feb. 2023|
|Erwartete Dividende & Rendite||N/A (N/A)|
Before next-generation sequencing (NGS) came along, children and families with rare and undiagnosed genetic diseases often faced years-long diagnostic odysseys.
While visiting her grandparents in Florida, 17-year-old Kate frequented a pond near their house and spent time observing the various species of fish living there.
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in Arizona, representatives from Illumina, a global leader in DNA sequencing and array-based technologies, joined approximately 2000 molecular diagnostic ...